Peer Review History

Original SubmissionAugust 4, 2022
Decision Letter - Diego Raimondo, Editor

PONE-D-22-21731

Complications following surgeries for endometriosis: a systematic review protocol

PLOS ONE

Dear Dr. Boutin,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 02 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Diego Raimondo

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Partly

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Complications after endometriosis surgery is a very important topic and any attempt to analyze their frequency and determinants is welcome. In this manuscript, authors present a protocol for studying complications rates following each type of surgeries for endometriosis and determinants of those complications.

There are several pitfalls that must be addressed before accepting it for publication:

1.- In the Search Strategy section, only 3 databases are included: MEDLINE (via PubMed), EMBASE, and the Cochrane Library. However other important electronic databases (such as Web of Science, Wanfang data, ClinicalTrials, NLM Gateway, Google Scholar, or BIOSIS preview) may give also important information. The authors should explain why them are not searching those database.

2.- As the review wi bell reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis format, the inclusion criteria should be sufficiently followed by PICOS (P: participants, I: intervention, C: comparison, O: outcomes, S: study design) format.

3.- The Cochrane Collaboration is more suitable for randomized controlled trials, and it is expected that all the included studies will be nonrandomized controlled trials [3]. Therefore, Downs and Black Tools (27 items with a total score of 29) are recommended for authors (SH Downs, N. Black. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health: 1998; 52, 377-384)

4.-The authors should clarify and more clearly define some of the terms they will use to explain characteristics of the study, the participants, and the potential determinants of complications. For example, how they will define or classify “symptoms”: will it be pain? severity of pain? intestinal or urinary symptoms? infertility?. How they will define “severity of endometriosis”? by using ASRM classification? If yes, it is well known that this classification has a bad correlation with surgical complications. If they opt by using ENZIAN classification, how they will built the final ENZIAN score?. Finally, although other definitions should be also provided, one the most important missing definition is the core of this protocol: how the author will define “surgical complication” and how they will define “major and minor complications”?. Other important missing definitions are how they will define “level care of centers”, “expertise of the surgery team”… Furthermore, the authors should explain why they are not taking in account other confounding factors as the association with adenomyosis is or if they will consider as a complication of endometriosis surgery the impairment of ovarian function frequently seen after ovarian endometrioma stripping.

Reviewer #2: Dear

Thank you to giving me the chance to review this interesting protocol on a very important topic

for the management of endometriosis

In order to explain better to the readers the importance of some important factors influencing iatrogenic complications (ie ureteral stent, parametrial or vaginal mucosa

Involvement) related to deep infiltrating endometriosis surgery I suggest to include and briefly comments some relevant articles (eg doi 10.1002/ijgo.14089, 10.1002/ijgo.13959, 10.1111/aogs.13824).

I believe that is important to list exauatively all complications that will be assessed, both de novo functional than organic ones.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

We would like to thank the reviewers’ thorough comments. We have provided answers below and highlighted the changes made in the manuscript with tracked edits.

Comments to the Author

Reviewer #1: Complications after endometriosis surgery is a very important topic and any attempt to analyze their frequency and determinants is welcome. In this manuscript, authors present a protocol for studying complications rates following each type of surgeries for endometriosis and determinants of those complications.

There are several pitfalls that must be addressed before accepting it for publication:

1.- In the Search Strategy section, only 3 databases are included: MEDLINE (via PubMed), EMBASE, and the Cochrane Library. However other important electronic databases (such as Web of Science, Wanfang data, ClinicalTrials, NLM Gateway, Google Scholar, or BIOSIS preview) may give also important information. The authors should explain why them are not searching those databases.

ANSWER: We have added searches of Web of Science and Google Scholar. After removing the duplicates, we did not find any new studies. We corrected the protocol to reflect these additional searches. Considering our eligibility criteria, we estimate the inclusion of the databases listed and search of references of included articles will ensure a very high sensitivity of our search.

Line 36-37 & 114-115: “We will search Medline (via PubMed), Embase, the Cochrane Library, Web of Science, and Google Scholar to identify all eligible studies.”

2.- As the review will be reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis format, the inclusion criteria should be sufficiently followed by PICOS (P: participants, I: intervention, C: comparison, O: outcomes, S: study design) format.

ANSWER: We changed the presentation of the eligibility criteria to make explicit the PICOS. See Table 1. Since the aim is descriptive, there will be no comparison of interventions. Hence, no comparison group is explicitly presented.

3.- The Cochrane Collaboration is more suitable for randomized controlled trials, and it is expected that all the included studies will be nonrandomized controlled trials [3]. Therefore, Downs and Black Tools (27 items with a total score of 29) are recommended for authors (SH Downs, N. Black. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health: 1998; 52, 377-384)

ANSWER: The Downs and Black tool is a checklist looking a study quality and includes items related to reporting quality for example. Tools which are aiming at assessing the risk of bias are a little different and more appropriate in our opinion to evaluate the internal validity of specific studies. As such, we preferred to use the ROBINS-I tool developed by the Cochrane Collaboration, not to be confused with the RoB2 (Cochrane risk-of-bias tool for randomized trials). The ROBINS-I was specifically developed for the assessment of the risk of bias of non-randomized studies. We clarified that the tool is for non-randomized studies (Sterne et al., 2019).

REF: Sterne, J. A., Hernán, M. A., McAleenan, A., Reeves, B. C., & Higgins, J. P. (2019). Assessing risk of bias in a non-randomized study. In Cochrane Handbook for Systematic Reviews of Interventions (pp. 621-641). https://doi.org/https://doi.org/10.1002/9781119536604.ch25

Line 160-162: ”The Cochrane collaboration tool for the assessment of the “Risk Of Bias in Non-randomized Studies of Interventions” (ROBINS-I) will be used to assess the risk of bias in individual studies (20). “

4.-The authors should clarify and more clearly define some of the terms they will use to explain characteristics of the study, the participants, and the potential determinants of complications. For example, how they will define or classify “symptoms”: will it be pain? severity of pain? intestinal or urinary symptoms? infertility?. How they will define “severity of endometriosis”? by using ASRM classification? If yes, it is well known that this classification has a bad correlation with surgical complications. If they opt by using ENZIAN classification, how they will built the final ENZIAN score?. Finally, although other definitions should be also provided, one the most important missing definition is the core of this protocol: how the author will define “surgical complication” and how they will define “major and minor complications”?. Other important missing definitions are how they will define “level care of centers”, “expertise of the surgery team”… Furthermore, the authors should explain why they are not taking in account other confounding factors as the association with adenomyosis is or if they will consider as a complication of endometriosis surgery the impairment of ovarian function frequently seen after ovarian endometrioma stripping.

ANSWER: We will conduct subgroup analysis by indication of surgeries (infertility, or pain) which are reported in most studies. However, we will not analyze data regarding fertility rates or pain following surgery as outcomes. Based on studies' reports, endometriosis severity is categorized by rASRM or/and ENZIAN. Gynecological experts in our team will be consulted if necessary to dichotomize studies in two groups according to these variables and depending on available data. Any ambiguity in the reported data will also be referred to the authors of the original studies. We will define surgical complications as any complications (composite outcome) which occur during surgery (intraoperative complications) and after the surgery (post-operative complications). Furthermore, a post-operative complication related to surgery generally occurs shortly after the procedure. Therefore, after consulting our expert, we remove complications occurring after one year from the manuscript. Therefore, postoperative complications are reported at 30 days and at three months following surgery when possible. You will find the list of complication as a table below. The symptoms of endometriosis after the surgery such as pain or fertility rate are not considered as part of postoperative complications in this study.

Regarding the major or minor complications, we use the Clavien–Dindo classification (grade I-II: minor complications, grade III-IV: major complications, grade V: death). This classification relies on grading complications based on the therapy used to treat the complication. A gynecological expert in our team will be consulted is it is necessary For the level of care, we will classify them as rural/community/regional hospitals versus academic/national/specialized hospitals versus unknown or mixed hospitals.

We planned to extract expertise of surgeons from the included articles when available. However, we expect there will be a high degree of heterogeneity in the way it is reported, and no official classification is available. Hence, we will report this information as part of descriptive analyses, or will create categories if deemed appropriate after consultation with clinicians and method experts in our group. The manuscript has been modified accordingly. The adenomyosis information will be collected if it is available in the studies for subgroup analysis. Regarding the ovarian reserve following surgical excision of ovarian endometriomas, as mentioned before we will not consider fertility rates as an outcome in this study.

Line 147-155: “[Our primary outcome will be a composite outcome of any intraoperative and postoperative complications (including conditions such as hemorrhage; organ injury; nerve damages including urinary voiding dysfunction, and urinary retention; open surgery conversion; mortality; postoperative reintervention; readmission after discharge from hospital; length of surgery; and length of hospital stay). The full list of complications is provided in the S2 Appendix. In addition, We will categorize complications as intraoperative complications, which occur during surgery, and postoperative complications, which occur after surgery. Postoperative complications will be reported within 30 days and three months after the surgery.]”

Line 165-175: “[The severity of endometriosis will be classified according to the revised American Society for Reproductive Medicine (rASRM) or/and ENZIAN. In addition, the level of care will be classified as rural/community/regional hospitals versus academic/national/specialized hospitals versus unknown or mixed hospitals. When surgeon expertise is available in the included articles, we will extract it. Since there is no official classification, we will create categories, if necessary, after consulting with clinicians and method experts in our group, unless we report it as a part of descriptive analyses. Furthermore, the Clavien-Dindo classification is used to classify major and minor complications (grades I-II: minor complications, grades III-IV: major complications, grade V: death). This classification determines the severity of complications by analyzing the therapy used to treat them. If necessary, we will consult a gynecological expert in our team.]”

Line 194-195: “[ The adenomyosis information also will be collected if it is available in the studies for subgroup analysis.]”

Reviewer #2: Dear

Thank you to giving me the chance to review this interesting protocol on a very important topic for the management of endometriosis. In order to explain better to the readers the importance of some important factors influencing iatrogenic complications (ie ureteral stent, parametrial or vaginal mucosa Involvement) related to deep infiltrating endometriosis surgery I suggest to include and briefly comments some relevant articles (eg doi 10.1002/ijgo.14089, 10.1002/ijgo.13959, 10.1111/aogs.13824).

I believe that is important to list exauatively all complications that will be assessed, both de novo functional than organic ones.

ANSWER: The table below, which contain the list of complications, is now provided in an appendix (S2) as a part of the data extraction form.

Composite outcome

Intraoperative complication

Post-operative complications (overall)

Post-operative complications in first month

Post-operative complications in three months

Grade I-II CD (minor complication)*

Grade III- V DC (major complications) *

Length of surgery

Readmission

Length of hospitalization

Open surgery conversion

Post-operative reintervention

Laparoscopic revision

laparotomy

Infection

Wound infection

Urinary tract infection

Vaginal infection

Abscess

Pyelonephritis

Cellulitis

Sepsis

Fever/pyrexia

Vascular repair

Venous thromboembolism

Thrombophlebitis

Pulmonary embolus

pneumothorax

Damage to blood vessels

Genitourinary tract injury

Cystotomy

Ureteral injury (transection)

Vesicovaginal fistula

Ureterovaginal fistula

Urinary retention

Bladder atony

voiding dysfunction

self-catheterization (< and > 30 days)

Gastrointestinal tract injury

Injury to gastrointestinal tract

Anastomotic dehiscence/anastomotic leak syndrome

Rectovaginal fistula

Rectal stenosis

Rectal perforation

ileostomy

Bleeding

Blood transfusion

Hematoma

Vascular injury

Vaginal cuff dehiscence

Nerve injury

Repair to bladder

Repair to ureter

Repair to bowel

Other complications¶

* Grade I: was assigned to any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions. Allowed therapeutic regimens are drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes, and physiotherapy. This grade also includes wound infections opened at the bedside;

Grade II: Requiring pharmacological treatment with drugs other than such allowed for Grade I complications. Blood transfusions and total parenteral nutrition are also included;

Grade III: requiring surgical, endoscopic, or radiological intervention;

Grade III-a: intervention not under general anesthesia;

Grade III-b: intervention under general anesthesia;

Grade IV: life-threatening complication (including CNS complications) requiring IC/ICU-management;

Grade IV-a: single organ dysfunction Grade IV-b: multi organ dysfunction;

Grade V: death of a patient.

¶ Other complications included accidental cut, puncture, perforation, or hemorrhage during medical care and surgical procedures as the cause of abnormal reaction of patient or later complication

Line 74-76: “[In addition, iatrogenic pelvic organ dysfunction can happen due to accidental damage to pelvic nerves in complete excision of deep-infiltrating endometriosis despite practices in nerve-sparing surgeries.]”

Attachments
Attachment
Submitted filename: PONE-D-22-21731_R1_ResponseToReviewers.pdf
Decision Letter - Diego Raimondo, Editor

Complications following surgeries for endometriosis: a systematic review protocol

PONE-D-22-21731R1

Dear Dr. Boutin,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Diego Raimondo

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The questions raised by this reviewer have been answered and the paper is now worthy of publication.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Formally Accepted
Acceptance Letter - Diego Raimondo, Editor

PONE-D-22-21731R1

Complications following surgeries for endometriosis: a systematic review protocol

Dear Dr. Boutin:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Diego Raimondo

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .